{"GHMDC classification":["Diagnosis"],"GHMDC health topic":["Tuberculosis"],"GHMDC manufacturer coordinates":["37.123225, -78.492772222222"],"GHMDC manufacturer location":["Virginia, United States"],"GHMDC scope":["Clinical trial"],"Page SDG":["SDG03 Good health and well-being"],"Page URL":["https://www.appropedia.org/Global_Health_Medical_Device_Compendium/Signature_Mapping_TBDx"],"Page affiliations":["Appropedia Foundation","University of Michigan"],"Page authors":["User:Lonny","User:Chriswaterguy","User:Emilio","Kathleen Sienko","Amir Sabet Sarvestani"],"Page description":["With drug-resistant strains of TB outpacing the effectiveness of available treatments, this disease is again on the rise, infecting more than 8 million people every year. As the current treatments are expensive (up to 40000$), TB is prevalent in resource-limited settings. The disease is also especially deadly to those with HIV."],"Page image":["File:TBDx.jpg"],"Page language":["en"],"Page license":["CC-BY-SA-3.0"],"Page parent":["Global Health Medical Device Compendium"],"Page root":["Global Health Medical Device Compendium"],"Page title":["Global Health Medical Device Compendium/Signature Mapping TBDx"],"Page views":[116],"Page year":["Wednesday, 01-Jan-14 00:00:00 UTC"],"Modification date":["Thursday, 10-Sep-26 14:27:25 UTC"]}